Framingham Company Archives - Framingham SOURCE

Framingham Company’s Study Provides Biological Insights Into The Increased Incidence Of COVID-19 In The African American Population

September 9, 2020September 9, 2020 editor African American, BERG, Coronavirus, Framingham Company, Health, Journal of Racial and Ethnic Health Disparities

Share, email, print, bookmark SOURCE reports.

FRAMINGHAM – BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, yesterday,

Business Health

Framingham-Based Kephera Diagnostics Launches Testing for COVID-19 Antibodies

August 5, 2020August 5, 2020 editor antibodies testing, Coronavirus, Framingham Company, Kephera Diagnostics

Share, email, print, bookmark SOURCE reports.

FRAMINGHAM – Kephera Diagnostics announced today, August 5, it has been approved as a CLIA certified laboratory by the Massachusetts

Business

Framingham Company Receives Approval Wound-Care Product in Europe

April 13, 2020April 13, 2020 editor Arch Therapeutics, Framingham Company

Share, email, print, bookmark SOURCE reports.

The following is a press release FRAMINGHAM- Arch Therapeutics, Inc., a developer of novel liquid, gel and solid hemostatic and

Business Health

Framingham Company Will Begin COVID-19 Antibody Testing Monday; Could Produce 200 Results Per Hour

April 5, 2020April 5, 2020 editor Boston Heart Diagnostics, Coronavirus, Eurofins, Framingham Company

Share, email, print, bookmark SOURCE reports.

FRAMINGHAM – The Eurofins’ U.S. Clinical Diagnostics network announced blood-based antibody testing for Coronavirus SARS-CoV-2 will begin Monday, April 6 at Boston Heart